u/Competitive_Hour_181

The author claims HCWC is undervalued, generating about $30M in gross profits and record 2025 revenues of $78M while being valued under $10M. The mechanism is a buy-and-build strategy expanding to 19 locations across six states, which the author expects to drive similar or greater growth as demand for healthy food rises. The catalyst is management's stated aggressive focus on the buy-and-build strategy for 2026. The main stated risk is not explicitly given beyond reliance on continued growth.

The author argues SaverOne (SVRE) is a microcap whose recent naming among TIME's Top Inventions of 2025 is mainstream validation not yet priced in, given its tiny public float of roughly 900K shares and reportedly high short interest relative to that float. The mechanism is that in such a low-float environment even moderate volume can force rapid price discovery as shorts are squeezed. The stated catalyst is the TIME recognition plus potential volume; the author explicitly flags that this is a volatile microcap and comes with risk.